FDA Investigator Sripal R Mada, PhD

Sripal R Mada, PhD has inspections in 11 countries as of 26 Oct 2023. Sripal R Mada, PhD has collaborated with a combinined 4644 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
52
Last Inspection Date:
26 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Greece, India, United States of America, Canada, South Africa, Netherlands, Romania, Malaysia, United Kingdom of Great Britain and Northern Ireland, Spain, China
Co-Investigator(s):
Aimee J Edwin, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alia Legaux, Alice S Tsao, Allen F Hall, Amanda E Lewin, PhD, Ana C Lazo, Andrace Lde Yampert, Andrea A Branche, Andrea D Swingle, Andrea S Heise, Angela E Glenn, Anissa M Vargas, Ann Marie Karnick, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Barbara A Rusin, Barbara D Wright, Barbara J Rincon, Barbara Janine Breithaupt, Barbara M Frazier, Bei Y He, Benton M Ketron, Bijoy Panicker, Bonita S Chester, Brandy D Brown, Brunilda Torres, Byron Ho, DVM, Carl J Montgomery, Carla J Lundi, Carmen Y Fisher, Carol Mrivera Lopez, PhD, CDR Kimberly Y Martin, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles A Snipes, PhD, Charles D Brown, Christine M Smith, Claire M Minden, Clotia Cabbey Mensah, Corey K Reno, Courtney N Long, Craig A Garmendia, Cynthia L Rakestraw, Da Lin Yao, MD, PhD, Daniel J Roberts, Daniel L Aisen, David M Mcnew, David R Heiar, Dawn C Olenjack, Deborah S Hammond, Demitria J Xiradakis, Dina A Tallman, Dipesh K Shah, Douglas W Gronski, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dylan D Yao, MD, PhD, Edmund F Mrak, Jr, Eric S Pittman, Erie E Joneson, Farhana Khan, Felix Maldonado, Gabriel Davila, Gajendiran Mahadevan, PhD, Ganesh N Joshi, Gary T Greco, Gene D Arcy, George C Amedro, George J Flynn, Gerald N Mcgirl, DDS, Geraldine D Sanders, Ginger M Sykes, Gloria J Baca, MS, Hanna L Potter, Hasan A Irier, PhD, Helen B Ricalde, Himanshu Gupta, PhD, Iram R Hassan, PhD, Ivan E Reyes, Jacqueline A O'shaughnessy, PhD, Jacqueline S Warner, Jai P Singh, James A Liubicich, James D Bradley, James M Kewley, James R Birkenstamm, Jane M Kreis, Janete F Guardia, Jeanne J Thai, Jenniefer N Ruyu, Jennifer Alongie Vollom, Jennifer C Adams, Jennifer L Sheehan, Jennifer Lalama, Joanne M Schlossin, Joel D Hustedt, John A Iwen, John A Kadavil, PhD, John S Hartford, Jonathan G Matrisciano, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose O Hernandez, Joseph A Dinardo, Joseph R Haynes, Joy P Matthias, Julian C Hanson, Julie Scoma, Junho Pak, Jyoti B Patel, PhD, Ka L Wong, Kara A Scheibner, PhD, Karen L Kosar, Karen M Cooper, Karen M Kondas, Karl Auguste, Katherine Szestypalow, Kathryn A Krentz, Kelli N Hicks, Kellia N Hicks, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kham Phommachanh, Kimberley A Hoefen, Kimberly A Dux, Kirtida Patel, L Gnnmassimia Massimilla, PharmD, Larry K Austin, Laura E Garcia, Laura L Staples, Laureen F Kononen, Laverne Puckett, Lawrence Y Lee, PhD, LCDR Chad N Thompson, LCDR Jennifer H Rhyu, Leonard H Lavi, Li Hongpaul Yeh, PhD, Liming Zhang, Linda M Cheny, Linda R Kuchenthal, Linda S Leja, Lisa P Oakes, Lixia Cai, Makini Cobourne Duval, PhD, Margaret E Sarles, Margaret M Annes, Margaret M Sands, Marie A Fadden, Martin K Yau, PhD, Matthew A Spataro, Matthew B Casale, Matthew C Watson, Matthew R Dionne, Melanie M Walker, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael G Sinkevich, Michael P Anthony, Michael R Goga, Michelle D Haamid, Michelle M Noe, Michelle M Noe Varga, Mindy M Chou, Minh D Phan, Mohsen Rajabi Abhari, FDA, Mra Davism, Mra M Barbosar, Muralidhara B Gavini, PhD, Nancy A Bellamy, Nancy L Rolli, Natalie A Mickelsen, DVM, Nathan R Moon, Neil J Bonzagni, PhD MPH, Nicholas C Mendiola, Nicola M Fenty Stewart, Nilufer M Tampal, PhD, Niraj Mehta, Patrick D Stone, MS, Paul E Stein, Paul Mouris, Paula J Bretz, Paula M Laplant, Perry T Nichols, Peter R Lenahan, Philip F Istafanos, DMV, MS, Rebecca Rodriguez, Rene R Ramirez, Richard W Berning, Robert C Coleman, Robert C Steyert, Robert J Martin, Robert L Lewis, Jr, Rose Ljean Mary, Ruben C Ayala, PharmD, Russ E Davis, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Samuel T Walker, Sangeeta M Khurana, PhD, Scott B Laufenberg, Seongeun Cho (Julia), PhD, Sharon L Matson, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Stefanie R Cook, Stephanie Mangigian, MS/OSH, RN, Stuart W Russell, Susan D Yuscius, Susan M Jackson, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Tamil Arasu, PhD, Tara C Singh, Tawny L Colling, Teena H Aiken, Terri L Thomas, Thea C Grome, Theressa B Smith, Thomas W Gordon, Thomas W Nojek, Timothy T Kapsala, Toyin B Oladimeji, Tracey Asinjen Wiersma, Traci C Kelm, Valentino Fiorella, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Vickie J Kanion, Vlada Matusovsky, William D Tingley, Winston R Alejo, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xikui Nmi Chen, Yiyue Zhang (nmi), PhD, Young M Choi, PhD

Sripal R Mada, PhD's Documents

Publish Date Document Type Title
May, 2011 FDA 483 Parexel Bionanalytical Services Division - Form 483, 2011-05-17
November, 2013 EIR Charles River Laboratories - EIR, 2013-11-15
January, 2012 FDA 483 Barr Laboratories Inc. - Form 483, 2012-01-13
March, 2013 EIR Frontage Laboratories (Shanghai) Co., Ltd. - EIR, 2013-03-08
August, 2010 FDA 483 COVANCE BIOANALYTICAL SERVICES, LLC - Form 483, 2010-08-06
August, 2013 EIR Aliri USA Inc. - EIR, 2013-08-30
April, 2018 FDA 483 VIMTA LABS LIMITED - Form 483, 2018-04-23
January, 2017 FDA 483 Apotex Inc. BioClinical Development Bioanalytical Laboratory - Form 483, 2017-01-13
June, 2017 FDA 483 Laboratorios Rubio SA - Form 483, 2017-06-23
April, 2010 FDA 483 AAIPharma Services - Form 483, 2010-04-16
January, 2012 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2012-01-06
October, 2009 FDA 483 Biovail Contract Research - Form 483, 2009-10-30
June, 2018 FDA 483 Catalent Ontario Limited - Form 483, 2018-06-29
June, 2019 FDA 483 Novocol Pharmaceutical of Canada, Inc. - Form 483, 2019-06-18
June, 2013 FDA 483 QPS Bioserve India Private Limited - Form 483, 2013-06-21
March, 2011 EIR Medtox Laboratories, Inc. - EIR, 2011-03-11
May, 2011 EIR Parexel Bionanalytical Services Division - EIR, 2011-05-17
August, 2012 FDA 483 Syneos Health Clinique Inc - Form 483, 2012-08-10
December, 2012 FDA 483 ICON Development Solutions, LLC - Form 483, 2012-12-07
March, 2017 EIR VEEDA CLINICAL RESEARCH LIMITED - EIR, 2017-03-24
January, 2012 EIR Barr Laboratories Inc. - EIR, 2012-01-13
August, 2013 FDA 483 Aliri USA Inc. - Form 483, 2013-08-30
October, 2022 FDA 483 Primera Analytical Solutions Corporation - Form 483, 2022-10-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more